ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹286 Cr | ₹260 Cr | ₹372 Cr | ₹241 Cr | ₹142 Cr |
What is the latest Total Current Liabilities ratio of ORCHID PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹286 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹372 Cr |
| Mar2022 | ₹241 Cr |
| Mar2021 | ₹142 Cr |
How is Total Current Liabilities of ORCHID PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹286 Cr | 9.85 | |
| Mar2024 | ₹260 Cr | -30.09 | |
| Mar2023 | ₹372 Cr | 54.45 | |
| Mar2022 | ₹241 Cr | 69.46 | |
| Mar2021 | ₹142 Cr | - | |
Compare Total Current Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,575.2 Cr | 4.7% | 14.5% | 44.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 4.7% |
14.5% |
44.7% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses